These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 27079596

  • 1. Treatment of pediatric uveitis with adalimumab: the MERSI experience.
    Castiblanco C, Meese H, Foster CS.
    J AAPOS; 2016 Apr; 20(2):145-7. PubMed ID: 27079596
    [Abstract] [Full Text] [Related]

  • 2. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
    Deitch I, Amer R, Tomkins-Netzer O, Habot-Wilner Z, Friling R, Neumann R, Kramer M.
    Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):801-808. PubMed ID: 29455252
    [Abstract] [Full Text] [Related]

  • 3. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
    Díaz-Llopis M, Salom D, Garcia-de-Vicuña C, Cordero-Coma M, Ortega G, Ortego N, Suarez-de-Figueroa M, Rio-Pardo MJ, Fernandez-Cid C, Fonollosa A, Blanco R, Garcia-Aparicio AM, Benitez-Del-Castillo JM, Olea JL, Arevalo JF.
    Ophthalmology; 2012 Aug; 119(8):1575-81. PubMed ID: 22525047
    [Abstract] [Full Text] [Related]

  • 4. Adalimumab for the treatment of refractory active and inactive non-infectious uveitis.
    Lee JT, Yates WB, Rogers S, Wakefield D, McCluskey P, Lim LL.
    Br J Ophthalmol; 2018 Dec; 102(12):1672-1678. PubMed ID: 29459430
    [Abstract] [Full Text] [Related]

  • 5. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E, Leccese P, Olivieri I, Latanza L.
    Clin Exp Rheumatol; 2014 Dec; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [Abstract] [Full Text] [Related]

  • 6. Use of adalimumab in refractory non-infectious childhood chronic uveitis: efficacy in ocular disease--a case cohort interventional study.
    Sen ES, Sharma S, Hinchcliffe A, Dick AD, Ramanan AV.
    Rheumatology (Oxford); 2012 Dec; 51(12):2199-203. PubMed ID: 22923752
    [Abstract] [Full Text] [Related]

  • 7. Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III.
    Suhler EB, Adán A, Brézin AP, Fortin E, Goto H, Jaffe GJ, Kaburaki T, Kramer M, Lim LL, Muccioli C, Nguyen QD, Van Calster J, Cimino L, Kron M, Song AP, Liu J, Pathai S, Camez A, Schlaen A, van Velthoven MEJ, Vitale AT, Zierhut M, Tari S, Dick AD.
    Ophthalmology; 2018 Jul; 125(7):1075-1087. PubMed ID: 29429764
    [Abstract] [Full Text] [Related]

  • 8. Adalimumab therapy for refractory uveitis: a pilot study.
    Diaz-Llopis M, García-Delpech S, Salom D, Udaondo P, Hernández-Garfella M, Bosch-Morell F, Quijada A, Romero FJ.
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):351-61. PubMed ID: 18476805
    [Abstract] [Full Text] [Related]

  • 9. Long-term Experience with Anti-tumor Necrosis factor - α Therapy in the Treatment of Refractory, Non-infectious Intermediate, Posterior, and Panuveitis.
    Corredores Dieb J, Vofo B, Amer R.
    Ocul Immunol Inflamm; 2024 Aug; 32(6):932-939. PubMed ID: 36538811
    [Abstract] [Full Text] [Related]

  • 10. Adalimumab therapy for refractory childhood uveitis.
    Bravo-Ljubetic L, Peralta-Calvo J, Noval S, Pastora-Salvador N, Abelairas-Gómez J, Merino R.
    J AAPOS; 2013 Oct; 17(5):456-9. PubMed ID: 24160962
    [Abstract] [Full Text] [Related]

  • 11. Biological response modifier therapy for refractory childhood uveitis.
    Gallagher M, Quinones K, Cervantes-Castañeda RA, Yilmaz T, Foster CS.
    Br J Ophthalmol; 2007 Oct; 91(10):1341-4. PubMed ID: 17556427
    [Abstract] [Full Text] [Related]

  • 12. Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case series.
    Ruiz-Lozano RE, Mousa HM, Soifer M, Azar NS, Quiroga-Garza ME, Dzhaber D, Murillo S, Song A, Rabinovich CE, Perez VL.
    Int Ophthalmol; 2024 Sep 10; 44(1):376. PubMed ID: 39254907
    [Abstract] [Full Text] [Related]

  • 13. Quiescence and Subsequent Anterior Chamber Inflammation in Adalimumab-treated Pediatric Noninfectious Uveitis.
    Choe S, Heo JW, Oh BL.
    Korean J Ophthalmol; 2020 Aug 10; 34(4):274-280. PubMed ID: 32783419
    [Abstract] [Full Text] [Related]

  • 14. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
    Riancho-Zarrabeitia L, Calvo-Río V, Blanco R, Mesquida M, Adan AM, Herreras JM, Aparicio Á, Peiteado-Lopez D, Cordero-Coma M, García Serrano JL, Ortego-Centeno N, Maíz O, Blanco A, Sánchez-Bursón J, González-Suárez S, Fonollosa A, Santos-Gómez M, González-Vela C, Loricera J, Pina T, González-Gay MA.
    Semin Arthritis Rheum; 2015 Dec 10; 45(3):361-8. PubMed ID: 26092330
    [Abstract] [Full Text] [Related]

  • 15. Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis.
    Correll CK, Bullock DR, Cafferty RM, Vehe RK.
    Clin Rheumatol; 2018 Feb 10; 37(2):549-553. PubMed ID: 29103180
    [Abstract] [Full Text] [Related]

  • 16. [Systemic biological treatment in ophthalmology].
    Benyó F, Farkas A, Horváth H, Nagy ZZ, Szepessy Z.
    Orv Hetil; 2019 Nov 10; 160(44):1744-1750. PubMed ID: 31657252
    [Abstract] [Full Text] [Related]

  • 17. Adalimumab for juvenile idiopathic arthritis-associated uveitis.
    Magli A, Forte R, Navarro P, Russo G, Orlando F, Latanza L, Alessio M.
    Graefes Arch Clin Exp Ophthalmol; 2013 Jun 10; 251(6):1601-6. PubMed ID: 23446556
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.